https://wewillcure.com/insights/metabolic-diseases Latest content from Cure in Metabolic Diseases en Thu, 16 Jul 2026 19:58:03 GMT https://wewillcure.com/insights/metabolic-diseases/founder-stories/how-a-pcos-diagnosis-fueled-one-founders-mission-to-disrupt-womens-health https://wewillcure.com/insights/metabolic-diseases/founder-stories/how-a-pcos-diagnosis-fueled-one-founders-mission-to-disrupt-womens-health Tue, 15 Jul 2025 04:00:00 GMT Article https://wewillcure.com/insights/entrepreneurship/funding-and-models/how-entrepreneurs-are-looking-beyond-glp-1s-for-obesity-innovations https://wewillcure.com/insights/entrepreneurship/funding-and-models/how-entrepreneurs-are-looking-beyond-glp-1s-for-obesity-innovations Wed, 02 Jul 2025 04:00:00 GMT Article https://wewillcure.com/insights/entrepreneurship/funding-and-models/xseed-awards-minority-women-startups-drug-development https://wewillcure.com/insights/entrepreneurship/funding-and-models/xseed-awards-minority-women-startups-drug-development Wed, 07 May 2025 04:00:00 GMT Article https://wewillcure.com/insights/metabolic-diseases/founder-stories/novel-biologic-aims-to-stop-kidney-damage-before-it-turns-chronic https://wewillcure.com/insights/metabolic-diseases/founder-stories/novel-biologic-aims-to-stop-kidney-damage-before-it-turns-chronic Fri, 02 May 2025 04:00:00 GMT Article https://wewillcure.com/insights/metabolic-diseases/founder-stories/how-one-company-targets-dialysis-complications-with-novel-therapy https://wewillcure.com/insights/metabolic-diseases/founder-stories/how-one-company-targets-dialysis-complications-with-novel-therapy Thu, 01 May 2025 04:00:00 GMT Article https://wewillcure.com/insights/metabolic-diseases/investment/obesity-drug-market-charts-new-course-for-patients-investors https://wewillcure.com/insights/metabolic-diseases/investment/obesity-drug-market-charts-new-course-for-patients-investors Fri, 07 Mar 2025 05:05:00 GMT Article https://wewillcure.com/insights/medtech/metabolic-diseases/breaking-the-blood-barrier-in-metabolic-care-at-ces-2025 https://wewillcure.com/insights/medtech/metabolic-diseases/breaking-the-blood-barrier-in-metabolic-care-at-ces-2025 Wed, 05 Feb 2025 05:00:00 GMT Article https://wewillcure.com/insights/metabolic-diseases/reality-check-doctors-challenge-glp-1-magic-drug-narrative https://wewillcure.com/insights/metabolic-diseases/reality-check-doctors-challenge-glp-1-magic-drug-narrative Fri, 17 Jan 2025 05:00:00 GMT Article https://wewillcure.com/insights/metabolic-diseases/patients-use-glp-1-drugs-for-weight-loss-benefit-gains https://wewillcure.com/insights/metabolic-diseases/patients-use-glp-1-drugs-for-weight-loss-benefit-gains Wed, 15 Jan 2025 05:00:00 GMT White Paper https://wewillcure.com/insights/metabolic-diseases/specialty-physicians-on-using-glp-1-drugs-off-label https://wewillcure.com/insights/metabolic-diseases/specialty-physicians-on-using-glp-1-drugs-off-label Tue, 14 Jan 2025 05:00:00 GMT White Paper https://wewillcure.com/insights/ai-and-machine-learning/metabolic-diseases/ai-designed-therapy-for-inflammatory-bowel-disease-advances https://wewillcure.com/insights/ai-and-machine-learning/metabolic-diseases/ai-designed-therapy-for-inflammatory-bowel-disease-advances Mon, 16 Dec 2024 05:00:00 GMT Article https://wewillcure.com/insights/cell-and-gene-therapeutics/founder-stories/lexeo-therapeutics-revolutionizing-genetic-medicine-for-cardiovascular-and https://wewillcure.com/insights/cell-and-gene-therapeutics/founder-stories/lexeo-therapeutics-revolutionizing-genetic-medicine-for-cardiovascular-and Wed, 18 Sep 2024 04:00:00 GMT Article https://wewillcure.com/insights/care-delivery/metabolic-diseases/insights_article-arpa-hs-heroes-program-accelerates-preventive-health https://wewillcure.com/insights/care-delivery/metabolic-diseases/insights_article-arpa-hs-heroes-program-accelerates-preventive-health Mon, 12 Aug 2024 04:00:00 GMT Article https://wewillcure.com/insights/entrepreneurship/founder-stories/spotlight-on-xseed-award-finalist-daria-lizneva https://wewillcure.com/insights/entrepreneurship/founder-stories/spotlight-on-xseed-award-finalist-daria-lizneva Fri, 09 Aug 2024 04:00:00 GMT Article https://wewillcure.com/insights/metabolic-diseases/longevity-and-healthspan/mvp-insights_article-cambrian-bios-drug-strategy-for-age-related-diseases https://wewillcure.com/insights/metabolic-diseases/longevity-and-healthspan/mvp-insights_article-cambrian-bios-drug-strategy-for-age-related-diseases Wed, 17 Jul 2024 04:00:00 GMT Article https://wewillcure.com/insights/metabolic-diseases/therapeutics/mvp-whitepaper-what-doctors-really-think-of-glp-1-medications https://wewillcure.com/insights/metabolic-diseases/therapeutics/mvp-whitepaper-what-doctors-really-think-of-glp-1-medications Mon, 10 Jun 2024 20:00:00 GMT White Paper https://wewillcure.com/insights/metabolic-diseases/ai-and-machine-learning/mvp-insights_article-fighting-liver-disease-with-detection-ai-and-novel https://wewillcure.com/insights/metabolic-diseases/ai-and-machine-learning/mvp-insights_article-fighting-liver-disease-with-detection-ai-and-novel Wed, 24 Apr 2024 04:00:00 GMT Article https://wewillcure.com/insights/metabolic-diseases/founder-stories/a-bionic-pancreas-transforms-care-for-people-with-type-1-diabetes https://wewillcure.com/insights/metabolic-diseases/founder-stories/a-bionic-pancreas-transforms-care-for-people-with-type-1-diabetes Thu, 26 Oct 2023 08:00:00 GMT Article https://wewillcure.com/insights/metabolic-diseases/glp-1ra-report-as-an-article https://wewillcure.com/insights/metabolic-diseases/glp-1ra-report-as-an-article Thu, 16 Jul 2026 19:58:03 GMT White Paper